跳至主要内容
临床试验/NCT06624189
NCT06624189Enrolling By Invitation不适用

Active Choice Clinical Decision Support: Hepatocellular Carcinoma Screening in Patients With Cirrhosis

NYU Langone Health1 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2024年11月20日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
600
试验地点
1
主要终点
Percentage of Participants for whom the Physician Completed Ordering of the Pending Liver Ultrasound

研究概览

简要总结

The research team will evaluate the effectiveness of an auto-pended bot liver ultrasound order that will prompt providers at the time of encounter to place appropriate imaging orders for hepatocellular carcinoma (HCC) screening in patients with cirrhosis.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • cirrhosis diagnosis,
  • 6 months or more after since most recent imaging.

排除标准

  • previous liver transplant,
  • HCC diagnosis,
  • receiving hospice care,
  • completed external imaging in the past 6 months.

结局指标

主要结局

Percentage of Participants for whom the Physician Completed Ordering of the Pending Liver Ultrasound

时间窗: Day 1

次要结局

  • Percentage of Participants with Completed Liver Ultrasound Imaging(Day 1)
  • HCC Diagnosis Rate from Completed Liver Ultrasound Imaging(Day 1)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验